Brief: Cleveland Biolabs Says It Received Notice Of Delisting From Nasdaq On November 26
03/12/2019 22:19
Dec 3 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS - ON NOV 26, CO RECEIVED WRITTEN NOTICE
OF
DELISTING FROM LISTING QUALIFICATIONS STAFF OF NASDAQ STOCK
MARKET LLC - SEC FILING
Source: (https://bit.ly/2PcVvBF)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc